Kenter SB - Search Results

1

Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls.

Loot MA, Kenter SB, Au FL, van Galen WJ, Middelkoop E, Bos JD, Mekkes JR. Loot MA, et al. Among authors: kenter sb. Eur J Cell Biol. 2002 Mar;81(3):153-60. doi: 10.1078/0171-9335-00228. Eur J Cell Biol. 2002. PMID: 11998867

2

Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.

Hulsebos TJ, Kenter S, Verhagen WI, Baas F, Flucke U, Wesseling P. Hulsebos TJ, et al. Acta Neuropathol. 2014 Sep;128(3):439-48. doi: 10.1007/s00401-014-1281-3. Epub 2014 Apr 17. Acta Neuropathol. 2014. PMID: 24740647

3

SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis.

Hulsebos TJ, Kenter SB, Jakobs ME, Baas F, Chong B, Delatycki MB. Hulsebos TJ, et al. Among authors: kenter sb. Clin Genet. 2010 Jan;77(1):86-91. doi: 10.1111/j.1399-0004.2009.01249.x. Epub 2009 Nov 3. Clin Genet. 2010. PMID: 19912265

4

SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.

Hulsebos TJ, Kenter S, Siebers-Renelt U, Hans V, Wesseling P, Flucke U. Hulsebos TJ, et al. Am J Surg Pathol. 2014 Mar;38(3):421-5. doi: 10.1097/PAS.0000000000000110. Am J Surg Pathol. 2014. PMID: 24525513

5

Type 1 papillary renal cell carcinoma in a patient with schwannomatosis: Mosaic versus loss of SMARCB1 expression in respectively schwannoma and renal tumor cells.

Hulsebos TJ, Kenter S, Baas F, Nannenberg EA, Bleeker FE, van Minkelen R, van den Ouweland AM, Wesseling P, Flucke U. Hulsebos TJ, et al. Genes Chromosomes Cancer. 2016 Apr;55(4):350-4. doi: 10.1002/gcc.22338. Epub 2016 Jan 22. Genes Chromosomes Cancer. 2016. PMID: 26799435

6

Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.

Weterman MAJ, Kuo M, Kenter SB, Gordillo S, Karjosukarso DW, Takase R, Bronk M, Oprescu S, van Ruissen F, Witteveen RJW, Bienfait HME, Breuning M, Verhamme C, Hou YM, de Visser M, Antonellis A, Baas F. Weterman MAJ, et al. Among authors: kenter sb. Hum Mol Genet. 2018 Dec 1;27(23):4036-4050. doi: 10.1093/hmg/ddy290. Hum Mol Genet. 2018. PMID: 30124830 Free PMC article.

7

Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.

Christiaans I, Kenter SB, Brink HC, van Os TA, Baas F, van den Munckhof P, Kidd AM, Hulsebos TJ. Christiaans I, et al. Among authors: kenter sb. J Med Genet. 2011 Feb;48(2):93-7. doi: 10.1136/jmg.2010.082420. Epub 2010 Oct 7. J Med Genet. 2011. PMID: 20930055

8

Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.

van den Munckhof P, Christiaans I, Kenter SB, Baas F, Hulsebos TJ. van den Munckhof P, et al. Among authors: kenter sb. Neurogenetics. 2012 Feb;13(1):1-7. doi: 10.1007/s10048-011-0300-y. Epub 2011 Oct 26. Neurogenetics. 2012. PMID: 22038540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page